Addiction and mental health difficulties remain among the most misunderstood health conditions in society. Many people who struggle with substance use problems experience stigma, shame, and fear of being judged. These feelings can become major barriers to seeking help, often delaying treatment until problems have become more severe.

At Ardens Medical Centre in Dubai, we believe that addiction is a treatable medical condition, not a personal weakness. Every person deserves access to compassionate, evidence-based care without fear of judgement.

Opioid dependence is more common than many people realise

When people think about opioid addiction, they often think of illicit drugs such as heroin. However, dependence can also develop from prescription medications that are commonly used to treat pain.

Medications such as codeine, tramadol, morphine, oxycodone, and fentanyl can be highly effective when used appropriately, but prolonged use can sometimes lead to physical dependence. Many people find themselves continuing these medications simply to avoid withdrawal symptoms, even when they wish to stop.

The good news is that effective treatments are available.

A new approach: Long-Acting Injectable Buprenorphine (Buvidal® Depot)

One of the most significant advances in addiction treatment in recent years has been the introduction of Long-Acting Injectable Buprenorphine (LAIB), known by the brand name Buvidal® Depot.

Unlike traditional treatments that require daily medication, Buvidal® is administered as a weekly or monthly injection by a healthcare professional. This provides a steady level of medication in the body, helping to reduce cravings and withdrawal symptoms while allowing patients to focus on rebuilding their lives.

For many individuals, this can be a transformative treatment option. The need for daily medication is removed, treatment becomes more discreet, and patients often report feeling more free to concentrate on work, family, relationships, and long-term recovery.

What Does the Research Show?

A recent study published in BMJ Open and co-authored by Professor Yasir Abbasi (https://bmjopen.bmj.com/content/bmjopen/15/2/e090736.full.pdf) examined outcomes for people receiving long-acting injectable buprenorphine compared with traditional oral treatments for opioid dependence.

The study found that patients receiving injectable buprenorphine experienced meaningful improvements in quality of life over a twelve-month period. Many participants reported better overall wellbeing and greater stability in their recovery journey.

These findings add to a growing body of evidence suggesting that long-acting injectable treatments can play an important role in modern addiction care.

Supporting Recovery From Both Illicit and Prescription Opioids

Long-acting injectable buprenorphine can be used to support individuals who are dependent on heroin and other illicit opioids, as well as those who have developed dependence on prescribed opioid pain medications.

For many patients, treatment provides an opportunity to safely reduce and eventually stop opioid use while minimising the discomfort associated with withdrawal.

Recovery Is Possible

Seeking help for addiction can feel overwhelming, particularly when stigma and misconceptions remain common. However, recovery is possible, and effective treatments are available.

Innovative treatments such as Buvidal® Depot are helping many people regain control of their lives, improve their wellbeing, and move forward with confidence. Ardens Medical Centre is the first private facility to offer this to people who require it, after a thorough and holistic assessment.

If you or someone you know is struggling with opioid dependence—whether related to prescription pain medication or illicit opioid use—professional support is available. Early intervention can make a significant difference and help pave the way towards lasting recovery.